Medical Marijuana Profit Margin

The latest profit margin for MJNA is -9.28% as of June 2026. That compares with -0.42% in the prior-year period — down 2131.1% year over year. That is below the Healthcare sector average of 14.41%. Investors often review this figure alongside Medical Marijuana's historical trend and sector peers before judging valuation or financial health.

Over the past year, MJNA's profit margin moved from -0.42% to -9.28% — a 2131.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Medical Marijuana's valuation or profitability profile.

Against Healthcare companies, MJNA currently prints -9.28% for profit margin, while the sector average sits near 14.41%. That is roughly 164.4% below the sector mean. Large gaps often invite a closer look at Medical Marijuana's growth, margins, and balance sheet.

Profit Margin shows how effectively Medical Marijuana converts resources into returns. At -9.28%, MJNA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -0.42% in the prior-year period — down 2131.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MJNA's profit margin (-9.28%), review year-over-year change from -0.42%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.